Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Neurons show rhythmic activity at different frequencies in the desynchronized state

In the 17th century, the Dutch scientist Christiaan Huygens hanged two of his recently invented pendulum clocks on a wooden beam and observed that as time passed, the clocks aligned their beats.

2 Aug 2022

Timothy Huang receives $2.8 million to continue research on Alzheimer's disease

Timothy Huang, Ph.D., has been awarded $2.8 million by the National Institute on Aging (NIA) to continue his work on Alzheimer's disease.

2 Aug 2022

Gene therapy approach delays disease onset in humanized mouse models of familial ALS

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the progressive loss of motor neurons in the brain and spinal cord responsible for voluntary movements and muscle control.

2 Aug 2022

Microvascular disease and Alzheimer's associated with more white matter damage, more inflammation

Disease of the microscopic blood vessels that feed the white matter of our brain is associated with worse cognitive function and memory deficits in individuals with Alzheimer's, scientists report.

2 Aug 2022

Socioeconomic deprivation associated with increased dementia risk and faster memory decline

Socioeconomic deprivation, including neighborhood disadvantages and persistent low wages, are associated with higher dementia risk, lower cognitive performance and faster memory decline, according to several studies reported today at the Alzheimer’s Association International Conference 2022 in San Diego and virtually.

2 Aug 2022

ALZ-NET: First data collection and sharing network for new FDA-approved Alzheimer's treatments

ALZ-NET is the first network developed specifically for new FDA-approved Alzheimer's treatments, collecting real-world evidence on drug effectiveness and side effects over a long period of time.

1 Aug 2022

Experiences of racism linked to lower memory scores, worse cognition in midlife and old age

Experiences of structural, interpersonal and institutional racism are associated with lower memory scores and worse cognition in midlife and old age, especially among Black individuals, according to studies reported today at the Alzheimer’s Association International Conference 2022 in San Diego and virtually.

1 Aug 2022

The Alzheimer’s Association recognizes seven researchers for contributions to the field of dementia science

The Alzheimer’s Association will present seven awards at the Alzheimer’s Association International Conference 2022, recognizing researchers for their varied expertise, noteworthy achievements and innovative contributions to the field of Alzheimer’s and dementia science.

1 Aug 2022

Persistent loss of smell due to COVID-19 may better predict long-term cognitive, functional impairment

New insights into factors that may predict, increase or protect against the impact of COVID-19 and the pandemic on memory and thinking skills were revealed by multiple studies reported today at the Alzheimer’s Association International Conference 2022 in San Diego and virtually.

31 Jul 2022

Experts release appropriate use recommendations for Alzheimer’s disease blood biomarkers

Alzheimer’s disease blood biomarkers (BBMs) may revolutionize the diagnosis of Alzheimer’s in the future, but are not yet ready for widespread use, according to a newly-published article by leading international clinicians and researchers convened by the Alzheimer’s Association.

31 Jul 2022

Study shows the link between common viruses and onset of Alzheimer’s disease

Alzheimer's disease can begin almost imperceptibly, often masquerading in the early months or years as forgetfulness that is common in older age. What causes the disease remains largely a mystery.

29 Jul 2022

Hospices have become big business for private equity firms, raising concerns about end-of-life care

Hospice care, once provided primarily by nonprofit agencies, has seen a remarkable shift over the past decade, with more than two-thirds of hospices nationwide now operating as for-profit entities.

29 Jul 2022

Weill Cornell Medicine-led consortium secures $14 million grant to study emerging technologies for aging adults

A Weill Cornell Medicine-led consortium has been awarded a five-year, $14.7 million renewal grant from the National Institute on Aging of the National Institutes of Health for a research Center focused on employing emerging and existing technologies to help promote the well-being, quality of life and independence of diverse populations of older adults and provide support for older adults with cognitive impairments.

28 Jul 2022

Study reveals a direct connection between the vagus nerve and learning centers of the brain

Researchers at the University of Colorado Anschutz Medical Campus have shown a direct link between vagus nerve stimulation and its connection to the learning centers of the brain.

28 Jul 2022

Repurposing an antipsychotic drug to treat various types of cancer

To treat some of the psychosis issues associated with Parkinson's disease, physicians often prescribe pimavanserin, an antipsychotic drug that acts within the brain to prevent hallucinations and delusions.

28 Jul 2022

Physical and mental activities may help reduce dementia risk

Physical and mental activities, such as household chores, exercise, and visiting with family and friends, may help lower the risk of dementia, according to a new study published in the July 27, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

27 Jul 2022

People who eat more ultra-processed foods may have higher risk of dementia

People who eat the highest amounts of ultra-processed foods like soft drinks, chips and cookies may have a higher risk of developing dementia than those who eat the lowest amounts, according to a new study published in the July 27, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

27 Jul 2022

IU researchers evaluate the efficacy of a failed clinical trial drug for Alzheimer's using rigorous pipeline

Most drugs developed to treat Alzheimer's disease have for years been ineffective in clinical trials. Researchers from Indiana University School of Medicine recently evaluated the efficacy of a failed clinical trial drug using their rigorous pipeline.

25 Jul 2022

Identifying the right non-pharmacologic treatments for patients with memory impairment

What's the best way to improve your memory as you age? Turns out, it depends, a new study suggests. But your fourth-grade math teacher may have been onto something with that phrase to help you remember how to work out a complicated problem: Please Excuse My Dear Aunt Sally.

22 Jul 2022

New research may lead to early diagnosis of devastating mental health conditions

New research by Georgia State University's TReNDS Center may lead to early diagnosis of devastating conditions such as Alzheimer's disease, schizophrenia and autism - in time to help prevent and more easily treat these disorders.

22 Jul 2022

Alzheimer's Disease News and Research

Further Reading

Neurons show rhythmic activity at different frequencies in the desynchronized state

Timothy Huang receives $2.8 million to continue research on Alzheimer's disease

Gene therapy approach delays disease onset in humanized mouse models of familial ALS

Microvascular disease and Alzheimer's associated with more white matter damage, more inflammation

Socioeconomic deprivation associated with increased dementia risk and faster memory decline

ALZ-NET: First data collection and sharing network for new FDA-approved Alzheimer's treatments

Experiences of racism linked to lower memory scores, worse cognition in midlife and old age

The Alzheimer’s Association recognizes seven researchers for contributions to the field of dementia science

Persistent loss of smell due to COVID-19 may better predict long-term cognitive, functional impairment

Experts release appropriate use recommendations for Alzheimer’s disease blood biomarkers

Study shows the link between common viruses and onset of Alzheimer’s disease

Hospices have become big business for private equity firms, raising concerns about end-of-life care

Weill Cornell Medicine-led consortium secures $14 million grant to study emerging technologies for aging adults

Study reveals a direct connection between the vagus nerve and learning centers of the brain

Repurposing an antipsychotic drug to treat various types of cancer

Physical and mental activities may help reduce dementia risk

People who eat more ultra-processed foods may have higher risk of dementia

IU researchers evaluate the efficacy of a failed clinical trial drug for Alzheimer's using rigorous pipeline

Identifying the right non-pharmacologic treatments for patients with memory impairment

New research may lead to early diagnosis of devastating mental health conditions

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News